We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alan Sinclair

Prof Alan J Sinclair MSc, MD, FRCP

Visiting Chair in Diabetes Care, King’s College, London, United Kingdom, and Director, Diabetes Frail Ltd, Bedfordshire, United Kingdom

Professor Alan Sinclair is an international expert in diabetes and clinical gerontology and is Director of the Foundation for Diabetes Research in Older People at Diabetes Frail Ltd based in Bedfordshire, England. He has provided advice for the UK NICE organisation, Diabetes UK, ABCD, Joint British Diabetes Societies, Care Quality Commission (CQC) and the UK Government Department of Health on matters relating to diabetes in older people.

He has interests in ageing and frailty, nutrition, stroke illness, end of life diabetes care, care home diabetes and cognitive dysfunction/Alzheimer’s disease. He co-led the development of the IDF Guideline on Managing Older People with Type 2 Diabetes and is Chair of the European Diabetes Working Party for Older People (EDWPOP) which has produced three sets of international clinical guidance. Alan was previously designated a WHO Expert in Diabetes and recently appointed to a World Expert Group on Frailty by the WHO. He was awarded the Presidential Medal of the IAGG in 2013 for services to older people and diabetes. He is the author of many papers in the area of geriatrics, frailty, nutrition and diabetes. Professor Sinclair has been involved in collaboration in 7 EU-funded projects connected with frailty and older people including patients with diabetes.

Disclosures

Professor Sinclair has no conflicts of interest to declare.